Comparative Net Survival Analysis of Men and Women With Breast Cancer in Japan: A Population‐Based Study
Cancer Science · 2025
DOI: 10.1111/cas.70068 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Science, 2025. Verfasst von Daisy Sibale Mojoo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Breast Neoplasms, Male. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
While male breast cancer (MBC) remains a rare and understudied disease, comparatively little is known about its prognosis in contrast to female breast cancer (FBC). There is a paucity of large population‐based studies comparing the prognosis of MBC patients to FBC patients in Japan. This study analyzed 181,540 breast cancer cases, 1058 (0.6%) males and 180,482 (99.4%) females, from 12 prefectures in Japan diagnosed between 1993 and 2011. Five‐ and ten‐year net survival (NS) were estimated and stratified by sex, period, age, stage, and histological groups. Excess hazard ratios (EHR) were adjusted for period, age, stage, and histological group. Cochran's Q test was utilized to assess heterogeneity across these factors. The overall 5‐ and 10‐year NS estimates for MBC patients were 90.7% (95% CI: 86.3%–93.7%) and 83.7% (95% CI: 72.2%–90.8%), respectively, while those for FBC patients were 88.3% (95% CI: 88.1%–88.5%) and 79.1% (95% CI: 78.7%–79.4%), respectively. The survival of MBC patients was comparable to that of FBC patients, with EHR of 0.88 [95% CI: 0.70–1.09] and 0.86 [95% CI: 0.69–1.07] for 5‐ and 10‐year survival, respectively. Heterogeneity analysis revealed no significant sex‐based differences in survival across these strata. This study offers a comprehensive analysis of breast cancer survival in Japanese men and women and enhances understanding of MBC prognosis relative to FBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
- Department of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Division of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya, Japan.
- Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
- School of Nursing, University of Shizuoka, Shizuoka, Japan.
- Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
ORCID-Profile: Daisy Sibale Mojoo, Isao Oze, Yuriko N Koyanagi, Kayo Nakata, Hiromi Sugiyama, Yuri Ito, Tomohiro Matsuda, Keitaro Matsuo, Hidemi Ito
Förderung
- Japan Society for the Promotion of Science
- Ministry of Health, Labour and Welfare
Zitieren
APA
Sibale Mojoo, D., Oze, I., Tsuge, H., Taniyama, Y., Koyanagi, Y. N., Yamamoto, S., Hori, M., Nakata, K., Sugiyama, H., Miyashiro, I., Oki, I., Nishino, Y., Ito, Y., Katanoda, K., Shibata, A., Matsuda, T., Matsuo, K., & Ito, H. (2025). Comparative Net Survival Analysis of Men and Women With Breast Cancer in Japan: A Population‐Based Study. Cancer Science. https://doi.org/10.1111/cas.70068
Vancouver
Sibale Mojoo D, Oze I, Tsuge H, Taniyama Y, Koyanagi YN, Yamamoto S, et al. Comparative Net Survival Analysis of Men and Women With Breast Cancer in Japan: A Population‐Based Study. Cancer Science. 2025. doi:10.1111/cas.70068
BibTeX
@article{SibaleMojoo2025,
author = {Sibale Mojoo, Daisy and Oze, Isao and Tsuge, Hiroshi and Taniyama, Yukari and Koyanagi, Yuriko N and Yamamoto, Sayaka and Hori, Megumi and Nakata, Kayo and Sugiyama, Hiromi and Miyashiro, Isao and Oki, Izumi and Nishino, Yoshikazu and Ito, Yuri and Katanoda, Kota and Shibata, Akiko and Matsuda, Tomohiro and Matsuo, Keitaro and Ito, Hidemi},
title = {Comparative Net Survival Analysis of Men and Women With Breast Cancer in Japan: A Population‐Based Study},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.70068}
}
EUVIMED